What companies are 4171.TWO's competitors?

GeneReach Biotechnology Corp. (4171.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 4171.TWO compare to its peers?

The peer comparison table on this page shows GeneReach Biotechnology Corp. (4171.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 4171.TWO operate in?

GeneReach Biotechnology Corp. (4171.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

4171.TWO

GeneReach Biotechnology Corp.

TWO·Biotechnology · Healthcare

NT$17.35NT$0.20−1.14%

Market capNT$994.20M·Aug 26 5:30 AM UTC

Frequently Asked Questions About 4171.TWO

What companies are 4171.TWO's competitors?: GeneReach Biotechnology Corp. (4171.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 4171.TWO compare to its peers?: The peer comparison table on this page shows GeneReach Biotechnology Corp. (4171.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 4171.TWO operate in?: GeneReach Biotechnology Corp. (4171.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

4171.TWO

GeneReach Biotechnology Corp.

TWO·Biotechnology · Healthcare

NT$17.35NT$0.20−1.14%

Market capNT$994.20M·Aug 26 5:30 AM UTC

Peers


7427.TWO	Great Novel Therapeutics Biotech & Medicals	NT$75.30	NT$4.0B
4131.TWO	NeoCore Technology Co., Ltd.	NT$33.00	NT$1.3B
6564.TWO	Enimmune corporation	NT$16.80	NT$1.2B
6496.TWO	Excelsior Biopharma Inc.	NT$24.90	NT$1.2B
6850.TWO	BiOptic Inc.	NT$33.50	NT$1.1B
6810.TWO	Bio Preventive Medicine Corp.	NT$21.95	NT$1.1B
7725.TWO	LabTurbo Biotech Corporation	NT$22.50	NT$1.1B
6872.TWO	NaviFUS Corp.	NT$15.05	NT$1.1B
6814.TWO	Lukas Biomedical Inc.	NT$19.90	NT$833.3M
6827.TWO	MegaPro Biomedical Co., Ltd	NT$10.35	NT$821.1M

Frequently Asked Questions About 4171.TWO

What companies are 4171.TWO's competitors?: GeneReach Biotechnology Corp. (4171.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 4171.TWO compare to its peers?: The peer comparison table on this page shows GeneReach Biotechnology Corp. (4171.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 4171.TWO operate in?: GeneReach Biotechnology Corp. (4171.TWO) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.